The HLA-A*31:01 allele: influence on carbamazepine treatment
Pharmacogenomics and Personalized Medicine · 2017-01 · Volume10 · 29-38
DOI: 10.2147/pgpm.s108598 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2017-01. Verfasst von Vincent Lai Ming Yip und 1 weiteren Autor:innen. Beteiligte Einrichtung: MRC Centre for Drug Safety Science, Institute of Translational Medicine, Department of Molecular and Clinical Pharmacology, University of Liverpool; …. Die Arbeit wurde bisher 30-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Centre for Drug Safety Science, Institute of Translational Medicine, Department of Molecular and Clinical Pharmacology, University of Liverpool; Department of Clinical Pharmacology, The Royal Liverpool and Broadgree…
Zitieren
APA
Yip, V. L., & Pirmohamed, M. (2017). The HLA-A*31:01 allele: influence on carbamazepine treatment. Pharmacogenomics and Personalized Medicine, Volume10, 29-38. https://doi.org/10.2147/pgpm.s108598
Vancouver
Yip VL, Pirmohamed M. The HLA-A*31:01 allele: influence on carbamazepine treatment. Pharmacogenomics and Personalized Medicine. 2017;Volume10:29-38. doi:10.2147/pgpm.s108598
BibTeX
@article{Yip2017,
author = {Yip, Vincent Lai Ming and Pirmohamed, Munir},
title = {The HLA-A*31:01 allele: influence on carbamazepine treatment},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2017},
volume = {Volume10},
pages = {29--38},
doi = {10.2147/pgpm.s108598}
}
EUVIMED